Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Open-Label Extension in Postherpetic Neuralgia
NCT00150436Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pregabalin in postherpetic neuralgia (PHN), sponsored by Pfizer. Started Feb 2002; status: completed.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00150436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150436.